Skip to content

Medical-device intelligence

Thermo Fisher Scientific: FDA clearances and recalls

Research Thermo Fisher Scientific in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

64 clearance records and 5 recall records in the covered releases, across 1 source company names and 16 product codes. Dated history runs from May 22, 2007 to Sep 25, 2025.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

69 matching records
Device / recordCompany in FDA recordSourceSource date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Colistin in the dilution range of 0.12-16 ug/mLK252062 · JWYThermo Fisher Scientific510(k)Sep 25, 2025FDA decision date
The Sensititre 18 - 24 hour MIC or Breakpoint Susceptibility System with Aztreonam/avibactam in the dilution range of 0.008/4 - 64/4 ug/mLK250575 · JWYThermo Fisher Scientific510(k)Sep 5, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Amikacin in the dilution range of 0.25-256 ug/mLK252014 · JWYThermo Fisher Scientific510(k)Aug 28, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ciprofloxacin in the dilution range of 0.002-64 ug/mLK250990 · JWYThermo Fisher Scientific510(k)Jun 30, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Ceftobiprole in the d…K242843 · JWYThermo Fisher Scientific510(k)Jun 20, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Vancomycin in the dilution range of 0.25-128 ug/mLK242659 · JWYThermo Fisher Scientific510(k)May 22, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Moxifloxacin in the dilution range of 0.008-16 ug/mLK242658 · JWYThermo Fisher Scientific510(k)Apr 15, 2025FDA decision date
The Sensititre YeastOne Susceptibility System with Micafungin in the dilution range of 0.008-16 µg/mLK243738 · NGZThermo Fisher Scientific510(k)Feb 27, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Linezolid in the dilu…K242905 · JWYThermo Fisher Scientific510(k)Feb 10, 2025FDA decision date
The Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with penicillin in the dil…K243201 · JWYThermo Fisher Scientific510(k)Feb 10, 2025FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Ceftobiprole in the dilution range of 0.008-16 ug/mLK243169 · JWYThermo Fisher Scientific510(k)Dec 19, 2024FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Linezolid in the dilution range of 0.25-32 ug/mLK242653 · JWYThermo Fisher Scientific510(k)Dec 5, 2024FDA decision date
The Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Daptomycin in the dilution range of 0.03-64 ug/mLK242657 · JWYThermo Fisher Scientific510(k)Nov 26, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Meropenem in the di…K242021 · JWYThermo Fisher Scientific510(k)Oct 9, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with ceftriaxone in the …K241967 · JWYThermo Fisher Scientific510(k)Oct 1, 2024FDA decision date
The Sensititre 20 - 24 hour Haemophilus influenzae/Streptococcus pneumoniae (HP) MIC or Breakpoint Susceptibility System with Imipenem in the dil…K240445 · JWYThermo Fisher Scientific510(k)May 16, 2024FDA decision date
Sensititre 20-24 hour Haemophilus influenzaelStreptococcus pneumoniae MIC or Breakpoint Susceptibility System with Ceftolozane-tazobactam in the …K232310 · JWYThermo Fisher Scientific510(k)Oct 31, 2023FDA decision date
The Sensititre YeastOne Susceptibility System with Rezafungin in the dilution range of 0.008-8ug/mLK231433 · NGZThermo Fisher Scientific510(k)Aug 31, 2023FDA decision date
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Dalbavancin in the dilution ra…K231988 · JWYThermo Fisher Scientific510(k)Aug 30, 2023FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Sulbactam-durlobactam in the dilution range of 0.015/4-32/4 ug/mLK231994 · JWYThermo Fisher Scientific510(k)Aug 25, 2023FDA decision date
Sensititre 20-24 hour Haemophilus influenzae/Streptococcus pneumoniae MIC, or Breakpoint Susceptibility System with Imipenem-relebactam in the di…K230935 · JWYThermo Fisher Scientific510(k)Jun 30, 2023FDA decision date
Sensititre 20-24-hour Haemophilus influenzae/Streptococcus pneumoniae MIC or Breakpoint Susceptibility System with Delafloxacin in the dilution r…K223844 · JWYThermo Fisher Scientific510(k)Mar 21, 2023FDA decision date
Sensititre YeastOne Susceptibility System with Fluconazole in the dilution range of 0.12-128ug/mLK221198 · NGZThermo Fisher Scientific510(k)Mar 10, 2023FDA decision date
The Sensititre YeastOne Susceptibility System with Caspofungin in the dilution range of 0.015-16ug/mlK221899 · NGZThermo Fisher Scientific510(k)Jan 20, 2023FDA decision date
Sensititre 18-24 hour MIC or Breakpoint Susceptibility System with Cefiderocol in the dilution range of 0.03-64 ug/mlK203741 · JWYThermo Fisher Scientific510(k)Dec 20, 2021FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗